Drug recall: Over 34,000 bottles of Diltiazem HCL capsules recalled due to this reason

Drug major had produced the lot at its Halol-based manufacturing facility in Gujarat.

437
Drug product Recall
Drug Recall

Last Updated on December 31, 2023 by The Health Master

New Delhi: Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.

As per the US Food and Drug Administration‘s (USFDA) Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules, which are used to treat angina, high blood pressure, and some types of irregular heartbeats.


Must read: Dissolution test: Importance in Pharma Industry


Princeton (New Jersey) based Sun Pharmaceutical Inc is recalling the affected lot due to “Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.”

The Mumbai-based drug major had produced the lot at its Halol-based manufacturing facility in Gujarat. The sffected lot was later distributed in the market by its US based unit.

The company initiated the Class II nationwide recall (US) on January 13 this year.

As per USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 

Drug recall: 5,720 tubes of Clobetasol Propionate Cream recalled due to this reason

Drug recall: These Lots of Levothyroxine sodium Oral Solution recalled

Drug recall: Bharat Biotech voluntarily recalls ChiroRaba vaccine due to this reason

Drug recall: Rifampin Capsules recalled due to this reason

Drug recall: Epinephrine API recalled due to this reason

Drug recall: Daptomycin for Injection recalled due to this reason

Dissolution test: Importance in Pharma Industry

Cosmetics: Chemicals in Nail Polish, Shampoo may raise Type 2 Diabetes risk

USFDA gives nod for generic Lenalidomide capsules

USFDA gives approval for Glycopyrrolate Injection USP

PCI issues notification on Exit Examination for D.Pharm course

Updated list of Medical Device Testing Laboratories (MDTLs)

Lux level in Industry (Pharma, Cosmetics, Homeopathy & Medical Devices)

Aerosols in Cosmetics

Latest IPC Alert – Indian Pharmacopoeia Commission

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news